Beckman Coulters Early Sepsis Indicator Receives 510k Clearance from the U.S. Food and Drug Administration

Beckman Coulter’s Early Sepsis Indicator Receives 510(k) Clearance from the U.S. Food and Drug Administration

A major milestone on its strategic mission to lead in sepsis diagnostics, Beckman Coulter has announced that its Early Sepsis Indicator has received 510(k) clearance from the U.S. Food and Drug Administration. Sepsis is a global healthcare crisis that affects more than 30 million people worldwide.1 The Early Sepsis Indicator is a first-of-its-kind, hematology-based cellular...

More From BioPortfolio on "Beckman Coulter’s Early Sepsis Indicator Receives 510(k) Clearance from the U.S. Food and Drug Administration"